← Open Payments lookup

LAKSHMIKANTHA KUMBLA: Open Payments

NPI 1265452098 · GREENVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$841 in 34 payments from 6 companies in 2025. Trend: 2023 $501 · 2024 $926 · 2025 $841

Food & beverage: $841
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$247
Otsuka America Pharmaceutical, Inc.4$177
E.R. Squibb & Sons, L.L.C.9$164
Alkermes, Inc.9$143
Janssen Pharmaceuticals, Inc3$64
Vanda Pharmaceuticals Inc.2$46

Products named: INGREZZA, COBENFY, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, FANAPT, ABILIFY MAINTENA.

Industry payments across AL — which companies pay providers there.